Please check your internet connection and try again.
# Ferrous Ascorbate
## Overview
Ferrous ascorbate is a chelated form of iron combined with ascorbic acid (vitamin C). The inclusion of ascorbic acid lowers gastric pH, creating an acidic environment that enhances the solubility and bioavailability of elemental iron, potentially reducing gastrointestinal side effects compared to traditional ferrous sulfate.
## Primary Indications
* Treatment of iron deficiency anemia (IDA).
* Prophylaxis of iron deficiency during pregnancy and lactation.
## Adult Dosing
* **Initial Dose:** 100 mg (elemental iron) once or twice daily.
* **Maintenance:** Once therapy completes, continue for 1–3 months to replenish body stores.
* **Maximum Dose:** Typically 200–300 mg elemental iron daily; high doses increase likelihood of GI side effects.
## Pediatric Dosing
* **General Practice:** Dosing is weight-based. Common practice is 3–6 mg/kg of elemental iron daily, divided into 1–3 doses.
* **Note:** Always verify specific weight-based protocols with local clinical guidelines or pediatric formularies, as regional concentrations of syrup formulations vary significantly.
## Dose Adjustments
* **Renal Impairment:** No specific adjustment required; however, monitor for iron overload in patients receiving frequent transfusions.
* **Hepatic Impairment:** Use caution in patients with iron-storage disorders (e.g., hemochromatosis).
## Contraindications
* Known hypersensitivity to iron or ascorbic acid.
* Hemosiderosis or hemochromatosis.
* Hemolytic anemia (unless iron deficiency is proven).
* Patients receiving repeated blood transfusions.
## Adverse Effects
* **Gastrointestinal:** Nausea, abdominal pain, constipation, diarrhea, and dark/black stools (common, harmless, but may mimic melena).
* **Dental:** Potential for temporary staining of teeth (if liquid form is used).
## Key Drug Interactions
* **Levodopa, Methyldopa, Bisphosphonates, Penicillamine, Quinolones, and Tetracyclines:** Iron significantly reduces absorption. Separate administration by at least 2 hours.
* **Antacids, Calcium, and PPIs:** Increase gastric pH, which reduces iron absorption. Administer at least 2 hours apart.
## Monitoring
* **Baseline:** CBC, serum ferritin, and percent transferrin saturation (TSAT).
* **Efficacy:** Reticulocyte count increases within 7–10 days; hemoglobin usually rises within 2–4 weeks.
* **Safety:** Monitor for GI symptoms and signs of iron toxicity; periodic assessment of ferritin levels helps prevent iron overload.
## Clinical Pearls
* **Absorption:** Best taken on an empty stomach; however, if GI intolerance occurs, it may be taken with food, acknowledging a potential reduction in absorption.
* **Vitamin C:** The ascorbate moiety serves as a reducing agent, keeping iron in the ferrous (Fe2+) state, which is preferred for intestinal absorption.
* **Stools:** Advise patients that darkened stools are expected and do not indicate internal bleeding.
* **Overdose:** Iron overdose is a medical emergency, particularly in children. Keep out of reach of children.
***
**Educational Disclaimer:** This information is for educational purposes only. Clinical practice guidelines vary by institution and country. Always verify specific dosing, safety precautions, and prescribing information using current institution-approved resources and the manufacturer's official Product Monograph before administration.
